{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T06:37:50Z","timestamp":1789799870277,"version":"4.0.1"},"reference-count":38,"publisher":"American Academy of Pediatrics (AAP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,11,1]]},"abstract":"<jats:p>Objective. Nonsteroidal antiinflammatory drugs (NSAIDs), mainly ibuprofen, are used extensively among children as analgesic and antipyretic agents. Our initial survey in the Kendang Kerbau Children's Hospital in Singapore showed NSAIDs to be the second most common adverse drug reaction-causing medications among children of Asian descent. We attempted to characterize the clinical and epidemiologic profile of NSAID reactions in this group of patients.<\/jats:p><jats:p>Methods. A retrospective case series from a hospital-based pediatric drug allergy clinic was studied. A diagnosis of NSAID hypersensitivity was made with a modified oral provocation test. Atopy was evaluated clinically and tested with a standard panel of skin-prick tests. We excluded from analysis patients with any unprovoked episodes of urticaria and\/or angioedema, patients &amp;lt;1 year of age, and patients who refused a diagnostic challenge test.<\/jats:p><jats:p>Results. Between March 1, 2003, and February 28, 2004, 24 patients, including 14 male patients (58%) and 18 Chinese patients (75%), with a mean age of 7.4 years (range: 1.4\u201314.4 years), were diagnosed as having cross-reactive NSAID hypersensitivity. A family history consistent with NSAID hypersensitivity was elicited for 17% of patients. None of the patients reported any episodes of angioedema\/urticaria unrelated to NSAIDs. The median cumulative reaction-eliciting dose was 7.1 mg\/kg. Facial angioedema developed for all patients (100%) and generalized urticaria for 38% of challenged patients, irrespective of age. There was no circulatory compromise, but respiratory symptoms of tachypnea, wheezing, and\/or cough were documented for 42% of patients. A cross-reactive hypersensitivity response to acetaminophen was documented for 46% of our patients through their history and for 25% through diagnostic challenge. Compared with patients with suspected adverse drug reactions to antibiotics, patients in the NSAID group were older (7.4 vs 4.8 years) and more likely to have a diagnosis of asthma (odds ratio: 7.5; 95% confidence interval: 3.1\u201319).<\/jats:p><jats:p>Conclusions. Early presentations of facial angioedema and urticaria are key features of dose- and potency-dependent, cross-reactive reactions to NSAIDs in a subpopulation of young, Asian, atopic children. Significant overlap with acetaminophen hypersensitivity, especially among very young patients, for whom the use of a cyclooxygenase-2-specific medication may not be feasible, severely limits options for medical antipyretic treatment.<\/jats:p>","DOI":"10.1542\/peds.2005-0969","type":"journal-article","created":{"date-parts":[[2005,10,18]],"date-time":"2005-10-18T00:33:22Z","timestamp":1129595602000},"page":"e675-e680","source":"Crossref","is-referenced-by-count":75,"title":["Early Presentation With Angioedema and Urticaria in Cross-reactive Hypersensitivity to Nonsteroidal Antiinflammatory Drugs Among Young, Asian, Atopic Children"],"prefix":"10.1542","volume":"116","author":[{"given":"Mona Iancovici","family":"Kidon","sequence":"first","affiliation":[{"name":"Department of Pediatric Medicine, Kendang Kerbau Children's Hospital, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liew Woei","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Pediatric Medicine, Kendang Kerbau Children's Hospital, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiang Wen","family":"Chin","sequence":"additional","affiliation":[{"name":"Department of Pediatric Medicine, Kendang Kerbau Children's Hospital, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lim Siok","family":"Hoon","sequence":"additional","affiliation":[{"name":"Department of Pediatric Medicine, Kendang Kerbau Children's Hospital, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"See","sequence":"additional","affiliation":[{"name":"Department of Pediatric Medicine, Kendang Kerbau Children's Hospital, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Goh","sequence":"additional","affiliation":[{"name":"Department of Pediatric Medicine, Kendang Kerbau Children's Hospital, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny Tang Poh","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Pediatric Medicine, Kendang Kerbau Children's Hospital, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oh Moh","family":"Chay","sequence":"additional","affiliation":[{"name":"Department of Pediatric Medicine, Kendang Kerbau Children's Hospital, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2005,11,1]]},"reference":[{"key":"2021120819501021500_R1","doi-asserted-by":"crossref","unstructured":"Chandrasekharan NV, Dai H, Roos KL, et al. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic\/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci USA.\u20082002;99:13926\u201313931","DOI":"10.1073\/pnas.162468699"},{"key":"2021120819501021500_R2","doi-asserted-by":"crossref","unstructured":"Jenkins C, Costello J, Hodge L. Systematic review of prevalence of aspirin-induced asthma and its implications for clinical practice. BMJ.\u20082004;328:434","DOI":"10.1136\/bmj.328.7437.434"},{"key":"2021120819501021500_R3","unstructured":"Strom BL, Carson JL, Schinnar R. The effect of indication on the risk of hypersensitivity reactions associated with tolmetin sodium versus other nonsteroidal antiinflammatory drugs. J Rheumatol.\u20081988;15:695\u2013699"},{"key":"2021120819501021500_R4","doi-asserted-by":"crossref","unstructured":"Settipane RA, Constantine HP, Settipane GA. Aspirin intolerance and recurrent urticaria in normal adults and children: epidemiology and review. Allergy.\u20081980;35:149\u2013154","DOI":"10.1111\/j.1398-9995.1980.tb01730.x"},{"key":"2021120819501021500_R5","unstructured":"Food and Drug Administration, Center for Drug Evaluation and Research. Drug and Device Approvals. Washington, DC: Food and Drug Administration; 1995"},{"key":"2021120819501021500_R6","doi-asserted-by":"crossref","unstructured":"Clarkson A, Choonara I. Surveillance for fatal suspected adverse drug reactions in the UK. Arch Dis Child.\u20082002;87:462\u2013466","DOI":"10.1136\/adc.87.6.462"},{"key":"2021120819501021500_R7","unstructured":"Adkinson NF Jr. Drug allergy. In: Adkinson NF Jr, Yunginger JW, Busse WW, et al, eds. Middleton's Allergy: Principles and Practice. 6th ed. Philadelphia, PA: Mosby;2003:1679\u20131694"},{"key":"2021120819501021500_R8","unstructured":"Idsoe O, Guthe T, Willcox RR, de Weck AL. Nature and extent of penicillin side-reactions, with particular reference to fatalities from anaphylactic shock. Bull World Health Organ.\u20081968;38:159\u2013188"},{"key":"2021120819501021500_R9","doi-asserted-by":"crossref","unstructured":"Sanchez-Borges M, Capriles-Hulett A. Atopy is a risk factor for non-steroidal anti-inflammatory drug sensitivity. Ann Allergy Asthma Immunol.\u20082000;84:101\u2013106","DOI":"10.1016\/S1081-1206(10)62748-2"},{"key":"2021120819501021500_R10","doi-asserted-by":"crossref","unstructured":"Rachelefsky GS, Coulson A, Siegel SC, Stiehm ER. Aspirin intolerance in chronic childhood asthma: detected by oral challenge. Pediatrics.\u20081975;56:443\u2013448","DOI":"10.1542\/peds.56.3.443"},{"key":"2021120819501021500_R11","doi-asserted-by":"crossref","unstructured":"Yunginger JW, O'Connell EJ, Logan GB. Aspirin-induced asthma in children. J Pediatr.\u20081973;82:218\u2013221","DOI":"10.1016\/S0022-3476(73)80157-X"},{"key":"2021120819501021500_R12","doi-asserted-by":"crossref","unstructured":"Lesko SM, Louik C, Vezina RM, Mitchell AA. Asthma morbidity after the short-term use of ibuprofen in children. Pediatrics.\u20082002;109 (2). Available at: www.pediatrics.org\/cgi\/content\/full\/109\/2\/e20","DOI":"10.1542\/peds.109.2.e20"},{"key":"2021120819501021500_R13","doi-asserted-by":"crossref","unstructured":"Kauffman RE, Lieh-Lai M. Ibuprofen and increased morbidity in children with asthma: fact or fiction?Paediatr Drugs.\u20082004;6:267\u2013272","DOI":"10.2165\/00148581-200406050-00001"},{"key":"2021120819501021500_R14","doi-asserted-by":"crossref","unstructured":"Stevenson DD, Sanchez-Borges M, Szczeklik A. Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes. Ann Allergy Asthma Immunol.\u20082001;87:177\u2013180","DOI":"10.1016\/S1081-1206(10)62221-1"},{"key":"2021120819501021500_R15","doi-asserted-by":"crossref","unstructured":"Sanchez-Borges M, Capriles-Behrens E, Caballero-Fonseca F. Hypersensitivity to non-steroidal anti-inflammatory drugs in childhood. Pediatr Allergy Immunol.\u20082004;15:376\u2013380","DOI":"10.1111\/j.1399-3038.2004.00159.x"},{"key":"2021120819501021500_R16","doi-asserted-by":"crossref","unstructured":"Sladek K, Dworski R, Soja J, et al. Eicosanoids in bronchoalveolar lavage fluid of aspirin-intolerant patients with asthma after aspirin challenge. Am J Respir Crit Care Med.\u20081994;149:940\u2013946","DOI":"10.1164\/ajrccm.149.4.8143059"},{"key":"2021120819501021500_R17","doi-asserted-by":"crossref","unstructured":"Sanak M, Levy BD, Clish CB, et al. Aspirin-tolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics. Eur Respir J.\u20082000;16:44\u201349","DOI":"10.1034\/j.1399-3003.2000.16a08.x"},{"key":"2021120819501021500_R18","doi-asserted-by":"crossref","unstructured":"Sanak M, Simon HU, Szczeklik A. Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma. Lancet.\u20081997;350:1599\u20131600","DOI":"10.1016\/S0140-6736(05)64015-9"},{"key":"2021120819501021500_R19","doi-asserted-by":"crossref","unstructured":"Choi JH, Park HS, Oh HB, et al. Leukotriene-related gene polymorphisms in ASA-intolerant asthma: an association with a haplotype of 5-lipoxygenase. Hum Genet.\u20082004;114:337\u2013344","DOI":"10.1007\/s00439-004-1082-1"},{"key":"2021120819501021500_R20","doi-asserted-by":"crossref","unstructured":"Choi JH, Lee KW, Oh HB, et al. HLA association in aspirin-intolerant asthma: DPB1*0301 as a strong marker in a Korean population. J Allergy Clin Immunol.\u20082004;113:562\u2013564","DOI":"10.1016\/j.jaci.2003.12.012"},{"key":"2021120819501021500_R21","doi-asserted-by":"crossref","unstructured":"Martin-Garcia C, Hinojosa M, Berges P, et al. Safety of a cyclooxygenase-2 inhibitor in patients with aspirin-sensitive asthma. Chest.\u20082002;121:1812\u20131817","DOI":"10.1378\/chest.121.6.1812"},{"key":"2021120819501021500_R22","doi-asserted-by":"crossref","unstructured":"Szczeklik A, Nizankowska E, Bochenek G, Nagraba K, Mejza F, Swierczynska M. Safety of a specific COX-2 inhibitor in aspirin-induced asthma. Clin Exp Allergy.\u20082001;31:219\u2013225","DOI":"10.1046\/j.1365-2222.2001.01075.x"},{"key":"2021120819501021500_R23","doi-asserted-by":"crossref","unstructured":"Gyllfors P, Bochenek G, Overholt J, et al. Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgetic drug celecoxib. J Allergy Clin Immunol.\u20082003;111:1116\u20131121","DOI":"10.1067\/mai.2003.1450"},{"key":"2021120819501021500_R24","doi-asserted-by":"crossref","unstructured":"Melillo G, Balzano G, Bianco S, et al. Report of the INTERASMA Working Group on Standardization of Inhalation Provocation Tests in Aspirin-Induced Asthma: oral and inhalation provocation tests for the diagnosis of aspirin-induced asthma. Allergy.\u20082001;56:899\u2013911","DOI":"10.1034\/j.1398-9995.2001.00025.x"},{"key":"2021120819501021500_R25","doi-asserted-by":"crossref","unstructured":"Stevenson DD. Diagnosis, prevention, and treatment of adverse reactions to aspirin and nonsteroidal anti-inflammatory drugs. J Allergy Clin Immunol.\u20081984;74:617\u2013622","DOI":"10.1016\/0091-6749(84)90115-5"},{"key":"2021120819501021500_R26","unstructured":"Stevenson DD, Simon RA, Zuraw BL. Sensitivity to aspirin and nonsteroidal antiinflammatory drugs. In: Adkinson NF Jr, Yunginger JW, Busse WW, et al, eds. Middleton's Allergy: Principles and Practice. 6th ed. Philadelphia, PA: Mosby;2003:1695\u20131710"},{"key":"2021120819501021500_R27","unstructured":"Capriles-Behrens E, Caplin J, Sanchez-Borges M. NSAID facial angiodema in a selected pediatric atopic population. J Investig Allergol Clin Immunol.\u20082000;10:277\u2013279"},{"key":"2021120819501021500_R28","doi-asserted-by":"crossref","unstructured":"Grattan CE. Aspirin sensitivity and urticaria. Clin Exp Dermatol.\u20082003;28:123\u2013127","DOI":"10.1046\/j.1365-2230.2003.01228.x"},{"key":"2021120819501021500_R29","doi-asserted-by":"crossref","unstructured":"Mastalerz L, Setkowicz M, Sanak M, Szczeklik A. Hypersensitivity to aspirin: common eicosanoid alterations in urticaria and asthma. J Allergy Clin Immunol.\u20082004;113:771\u2013775","DOI":"10.1016\/j.jaci.2003.12.323"},{"key":"2021120819501021500_R30","doi-asserted-by":"crossref","unstructured":"Van Sambeek R, Stevenson DD, Baldasaro M, et al. 5\u2032-Flanking region polymorphism of the gene encoding leukotriene C4 synthase does not correlate with the aspirin-intolerant asthma phenotype in the United States. J Allergy Clin Immunol.\u20082000;106:72\u201376","DOI":"10.1067\/mai.2000.107603"},{"key":"2021120819501021500_R31","unstructured":"Kidon MI, See Y. Adverse drug reactions in Singaporean children. Singapore Med J.\u20082004;45:574\u2013577"},{"key":"2021120819501021500_R32","doi-asserted-by":"crossref","unstructured":"Pastorello EA, Zara C, Riario-Sforza GG, Pravettoni V, Incorvaia C. Atopy and intolerance of antimicrobial drugs increase the risk of reactions to acetaminophen and nimesulide in patients allergic to nonsteroidal anti-inflammatory drugs. Allergy.\u20081998;53:880\u2013884","DOI":"10.1111\/j.1398-9995.1998.tb03995.x"},{"key":"2021120819501021500_R33","unstructured":"Stevenson DD. Anaphylactic and anaphylactoid reactions to aspirin and nonsteroidal anti-inflammatory drugs. Immunol Allergy Clin North Am.\u20082001;21:745\u2013768"},{"key":"2021120819501021500_R34","doi-asserted-by":"crossref","unstructured":"Nizankowska E, Bestynska-Krypel A, Cmiel A, Szczeklik A. Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma. Eur Respir J.\u20082000;15:863\u2013869","DOI":"10.1034\/j.1399-3003.2000.15e09.x"},{"key":"2021120819501021500_R35","doi-asserted-by":"crossref","unstructured":"Szczeklik A, Serwonska M. Inhibition of idiosyncratic reactions to aspirin in asthmatic patients by clemastine. Thorax.\u20081979;34:654\u2013657","DOI":"10.1136\/thx.34.5.654"},{"key":"2021120819501021500_R36","doi-asserted-by":"crossref","unstructured":"Bavbek S, Celik G, Ozer F, Mungan D, Misirligil Z. Safety of selective COX-2 inhibitors in aspirin\/nonsteroidal anti-inflammatory drug-intolerant patients: comparison of nimesulide, meloxicam, and rofecoxib. J Asthma.\u20082004;41:67\u201375","DOI":"10.1081\/JAS-120026063"},{"key":"2021120819501021500_R37","doi-asserted-by":"crossref","unstructured":"Sanchez BM, Capriles-Hulett A, Caballero-Fonseca F, Perez CR. Tolerability to new COX-2 inhibitors in NSAID-sensitive patients with cutaneous reactions. Ann Allergy Asthma Immunol.\u20082001;87:201\u2013204","DOI":"10.1016\/S1081-1206(10)62226-0"},{"key":"2021120819501021500_R38","doi-asserted-by":"crossref","unstructured":"Sanchez-Borges M, Caballero-Fonseca F, Capriles-Hulett A. Tolerance of nonsteroidal anti-inflammatory drug-sensitive patients to the highly specific cyclooxygenase 2 inhibitors rofecoxib and valdecoxib. Ann Allergy Asthma Immunol.\u20082005;94:34\u201338","DOI":"10.1016\/S1081-1206(10)61282-3"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/116\/5\/e675\/1024918\/zpe0110500e675.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/116\/5\/e675\/1024918\/zpe0110500e675.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T03:49:06Z","timestamp":1683258546000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/116\/5\/e675\/68092\/Early-Presentation-With-Angioedema-and-Urticaria"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11,1]]},"references-count":38,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2005,11,1]]},"published-print":{"date-parts":[[2005,11,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2005-0969","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11,1]]}}}